Jubilant Cadista Pharmaceuticals, Inc. is recalling 89,722 blister packs of MethylPREDNISolone Tablets, USP (4 mg), a prescription steroid medication. The recall was initiated because the tablets failed stability testing during an 18-month check, meaning the medication's potency or quality may not meet required standards over its full shelf life. Consumers who have this medication should contact their doctor or pharmacist for guidance on continuing their treatment.
The drug failed to maintain its required assay specifications during long-term testing, which could mean the medication is less effective than intended. Taking a sub-potent steroid could lead to inadequate treatment of the underlying inflammatory condition being managed.
Pharmacy refund and healthcare consultation
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.